RespireRx Pharmaceuticals Inc (RSPI): No mention if the funding will be suffic...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	186
Boards Moderated	0
Alias Born	10/25/2010

drfreely

Re: sparkyone post# 39181

Thursday, 09/25/2014 12:01:31 PM

Thursday, September 25, 2014 12:01:31 PM

No mention if the funding will be sufficient in and of itself to complete trials, and crunch data, but I'm hopeful that we'll be able to get S.P. traction now that some funding has been secured. However limited it might be, my hat's off to management. It's terrific p.r. at the very least, and an inducement to further private funding. We'll need the share price up considerably on positive test data before money can be raised with a stock offering, but we're headed in the right direction at long last.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent RSPI News

Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 12:45:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 12:30:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:01:32 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 01:03:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 01:30:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 01:45:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 01:45:18 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/17/2023 09:06:03 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 09:05:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 01:00:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 12:45:26 PM